Global Sleep Apnea Devices Market Outlook 2031
The global sleep apnea devices market size was valued at USD 4.84 billion in 2022 and is projected to reach USD 11.41 billion by 2031, expanding at a CAGR of 10% during the forecast period, 2023–2031. The growth of the market is attributed to the sleep disorders are projected to become more common as the geriatric population grows as life expectancy increases.
Sleep apnea is a kind of sleep disorder that occurs when a person has difficulty sleeping. The brain and other parts of the body receive less oxygen as a consequence. Snoring, breathing pauses, drowsiness after a night's sleep, morning headache, and other symptoms are all classic signs of sleep apnea. Sleep apnea devices are categorized into therapeutic and diagnostic devices.
Sleep apnea, if left untreated, can lead to excessive blood pressure, cardiovascular disease, obesity, and neurological problems. Obstructive apnea for sleep, central apnea for sleep, and complex apnea for sleep are the three main types of apneas for sleep.
Global Sleep Apnea Devices Market Trends, Drivers, Restraints, and Opportunities
- Increase in the number of individuals suffering from sleep apnea, increased awareness of the adverse consequences of sleep apnea and a rise in the number of overweight people is anticipated to spur the market expansion during the forecast period.
- Rising public awareness of the adverse effects of sleep apnea, as well as technical improvements in the sleep apnea device market, are major factors boosting the market expansion in the coming years.
- Growing demand for portable, effective, and improved sleep apnea solutions is projected to push the market growth during the forecast period.
- High cost of devices and lack of knowledge regarding obstructive sleep apnea (OSA) in emerging nations are estimated to hamper the market growth.
- Gradual shift in consumer preference for home healthcare devices is expected to create significant opportunities for the market players.
Scope of the Global Sleep Apnea Devices Market Report
The report on the global sleep apnea devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Sleep Apnea Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
By Types (Diagnostic Devices and Therapeutic Devices), Diagnostic Devices (Actigraphy Devices, Pulse Oximeters, and Polysomnography Devices (PSG)), Therapeutic Devices (Oxygen Devices, Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks and Accessories, and Adaptive Servo Ventilation (ASV) Devices), and End-Users (Home Care Settings, Sleep Laboratories & Hospitals, and Others)
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report
BMC Medical Co., Ltd.; Compumedics Limited; Curative Medical, Inc.; Fisher & Paykel Healthcare Limited; Invacare Corporation; Itamar Medical Ltd.; Natus Medical Incorporated; Nihon Kohden Corporation; Phillips Respironics; ResMed; Somnetics International, and Inc.; SOMNOmedics GmbH
Global Sleep Apnea Devices Market Segment Insights
Therapeutic devices segment is projected to hold a key market share
On the basis of types, the global sleep apnea devices market is bifurcated into diagnostic devices and therapeutic devices. The therapeutic devices segment is expected to represent a key share of the market in the coming years owing to the most typical devices used to treat sleep apnea are positive airway pressure (PAP) devices.
Continuous positive airway pressure (CPAP) devices are the favored option of therapy for OSA among PAP devices by healthcare practitioners globally. The remarkable effectiveness of CPAP and other PAP devices in the treatment of sleep apnea has helped in the global acceptance of therapeutic devices.
On the other hand, the diagnostic devices segment is anticipated to expand at a rapid pace during the forecast period due to the vast pool of undiagnosed patients and increasing awareness of available diagnostic and treatment options for sleep apnea among the general public, especially in emerging nations, the diagnostic device segment is expected to grow at a rapid pace.
Polysomnography Devices (PSG) segment is projected to account for a large market share
Based on diagnostic devices, the market is segmented into actigraphy devices, pulse oximeters, and polysomnography devices (PSG). The polysomnography devices (PSG) segment is expected to account for a key share of the market during the forecast period due to its multi-parameter test that monitors the patient's brain waves, blood oxygen levels, heart rate, and breathing, as well as eye and leg movements during the diagnostic procedure.
Pulse oximeters segment is expected to grow at a rapid pace
In terms of therapeutic devices, the global sleep apnea devices market is segregated into oxygen devices, positive airway pressure (PAP) devices, oral appliances, masks and accessories, and adaptive servo-ventilation (ASV) devices. The pulse oximeters segment is expected to hold a key share of the market in the coming years owing to their ease it becomes almost common equipment in hospitals and healthcare organizations.
Pulse oximetry is used in a variety of ways to explore and diagnose obstructive sleep apnea in both adults and children, it is used to evaluate blood hemoglobin oxygen saturation in a comparatively noninvasive manner over time.
Sleep Laboratories & Hospitals segment is anticipated to expand at a substantial CAGR
On the basis of end-users, the market is divided into Home Care Settings, Sleep Laboratories & Hospitals, and Others. The sleep laboratories & hospitals segment is expected to constitute a key share of the market during the forecast period due to patients' preferences for visiting hospitals and sleep laboratories for sleep apnea diagnosis.
Furthermore, hospitals and sleep labs are well-equipped with all of the diagnostic equipment that may contribute to the detection of sleep disorders by measuring brain activity, eye movement, heart rate, snoring, body movements, and other factors.
North America is anticipated to dominate the market
On the basis of regions, the global sleep apnea devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at an impressive CAGR during the forecast period. The regional market growth can be attributed to the rising prevalence of sleep apnea and the existence of appropriate reimbursement regulations that have been key factors in the region's increased adoption of sleep apnea devices.
Due to the region's shortened sleep duration, high healthcare costs, and rising prevalence of obstructive sleep apnea. Obstructive sleep apnea (OSA) is linked to obesity and growing older. One of the causes contributing to the increased frequency of sleep disorders in the United States is the country's aging population, which is combined with a large proportion of obese individuals.
The Global sleep apnea devices market has been segmented on the basis of
- Diagnostic Devices
- Therapeutic Devices
- Actigraphy Devices
- Pulse Oximeters
- Polysomnography Devices (PSG)
- Oxygen Devices
- Positive Airway Pressure (PAP) Devices
- Oral Appliances
- Masks and Accessories
- Adaptive Servo Ventilation (ASV) Devices
- Home Care Setting
- Sleep Laboratories & Hospitals
- Asia Pacific
- North America
- Latin America
- Middle East & Africa
- BMC Medical Co., Ltd.
- Compumedics Limited
- Curative Medical, Inc.
- Fisher & Paykel Healthcare Limited
- Invacare Corporation
- Itamar Medical Ltd.
- Natus Medical Incorporated
- Nihon Kohden Corporation
- Phillips Respironics
- Somnetics International, Inc.
- SOMNOmedics GmbH
Key players competing in the global sleep apnea devices market are BMC Medical Co., Ltd.; Compumedics Limited; Curative Medical, Inc.; Fisher & Paykel Healthcare Limited; Invacare Corporation; Itamar Medical Ltd.; Natus Medical Incorporated; Nihon Kohden Corporation; Phillips Respironics; ResMed; Somnetics International, and Inc.; SOMNOmedics GmbH.
Some of these players are adopting several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to increase their market shares.